Loading...
BRAIN Biotech AG
BNN.DE•XETRA
Healthcare
Biotechnology
€2.22
€-0.06(-2.63%)
BRAIN Biotech AG (BNN.DE) Financial Performance & Income Statement Overview
Review BRAIN Biotech AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.27%
↓ 1.27%
Operating Income Growth
-31.82%
↓ 31.82%
Net Income Growth
-34.40%
↓ 34.40%
Operating Cash Flow Growth
15.05%
↑ 15.05%
Operating Margin
-19.18%
↓ 19.18%
Gross Margin
54.88%
↑ 54.88%
Net Profit Margin
-25.94%
↓ 25.94%
ROE
-124.11%
↓ 124.11%
ROIC
-16.78%
↓ 16.78%
BRAIN Biotech AG (BNN.DE) Income Statement & Financial Overview
Review BRAIN Biotech AG's (BNN.DE) income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $13.11M | $14.24M | $13.19M | $27.20M |
Cost of Revenue | $5.88M | $6.55M | $6.12M | $26.07M |
Gross Profit | $7.22M | $7.68M | $7.07M | $1.13M |
Gross Profit Ratio | $0.55 | $0.54 | $0.54 | $0.04 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $0.00 | $5.94M | $5.01M |
Operating Expenses | $9.90M | $11.13M | $9.22M | $4.78M |
Total Costs & Expenses | $15.78M | $17.69M | $15.34M | $30.85M |
Interest Income | $70000.00 | -$62000.00 | $7000.00 | $5000.00 |
Interest Expense | $1.33M | $471000.00 | $621000.00 | $458000.00 |
Depreciation & Amortization | $1.21M | $1.31M | $1.18M | $2.34M |
EBITDA | -$1.56M | -$1.84M | -$1.14M | -$140000.00 |
EBITDA Ratio | -$0.12 | -$0.13 | -$0.09 | -$0.005 |
Operating Income | -$2.68M | -$3.45M | -$2.15M | -$3.65M |
Operating Income Ratio | -$0.20 | -$0.24 | -$0.16 | -$0.13 |
Other Income/Expenses (Net) | -$1.42M | -$167000.00 | -$786000.00 | -$653000.00 |
Income Before Tax | -$4.10M | -$3.62M | -$2.94M | -$4.09M |
Income Before Tax Ratio | -$0.31 | -$0.25 | -$0.22 | -$0.15 |
Income Tax Expense | -$63000.00 | $316000.00 | -$373000.00 | $168000.00 |
Net Income | -$4.03M | -$3.99M | -$2.57M | -$4.56M |
Net Income Ratio | -$0.31 | -$0.28 | -$0.19 | -$0.17 |
EPS | -$0.18 | -$0.18 | -$0.12 | -$0.21 |
Diluted EPS | -$0.18 | -$0.18 | -$0.12 | -$0.21 |
Weighted Avg Shares Outstanding | $21.85M | $21.64M | $21.43M | $21.85M |
Weighted Avg Shares Outstanding (Diluted) | $21.85M | $21.85M | $21.85M | $21.85M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan